Although reduced PHEX-mediated cleavage of pASARM also acts as an FGF23-independent mechanism for contributing to bone abnormalities in XLH [109–112], this process is exacerbated by FGF23-induced upregulation of OPN [108]. The gene discussed is SPP1; the disease is X-linked hypophosphatemia.